Bookmark
Forward
Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis.
Neelam Hassan, Emma Jane Davies, Benjamin George Faber, Harsha Gunawardena
Rheumatology (Oxford, England) 2021 May 14
Sizes of these terms reflect their relevance to your search.
No abstract available.
Citation
Neelam Hassan, Emma Jane Davies, Benjamin George Faber, Harsha Gunawardena.
Infliximab in a patient with treatment-resistant anti-SAE dermatomyositis.
Rheumatology (Oxford, England).
2021 May 14;60(5):e156-e158
Mesh Tags
Autoantibodies
Dermatologic Agents
Dermatomyositis
Female
Humans
Infliximab
Middle Aged
Treatment Outcome
Ubiquitin-Activating Enzymes
Substances
Autoantibodies
Dermatologic Agents
Infliximab
SAE1 protein, human
Ubiquitin-Activating Enzymes
PMID: 33221923
View Full Text